Proteomic profiling revealed an NRF2 gene signature in HNSCC that is associated with poor patient survival and increased NRF2 target gene expression, particularly HMOX1, GSTs and AKRs [254]. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.